Please provide your email address to receive an email when new articles are posted on . In older adults with treatment-resistant depression, bilateral theta burst stimulation was noninferior to ...

Transcranial magnetic stimulation, a form of non-invasive brain stimulation, has been used for the past 35 years to investigate brain function in health and disease. Applied to quantify causal changes ...

A new accelerated theta-burst stimulation (aTBS) protocol was safe and effective for treatment-resistant depression (TRD) in a randomized controlled trial and may offer a viable alternative to more ...

Despite its proven efficacy for unipolar depression, intermittent theta burst transcranial magnetic stimulation (iTBS) appears to be ineffective in alleviating symptoms of bipolar depression, new ...

COSTA MESA, Calif., March 21, 2022 /PRNewswire-PRWeb/ -- TMS Health and Wellness today announced the launch of the clinic's newest form of Transcranial Magnetic Stimulation (TMS) protocol, ...

neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS) protocol, available across its Apollo TMS Therapy System and ...

Dopamine (DA) is a neurotransmitter with an important influence on learning and memory, which is thought to be due to its ability to modulate plasticity at central synapses. Its actions at many ...

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

CRESSKILL, N.J. and JERUSALEM, April 26, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...

CRESSKILL, N.J. and JERUSALEM, April 26, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...